Automated Clinical Pathway for Inflammatory Bowel Disease Care

The University of Texas System (UT)

Status: Invitation-only

Conditions: Inflammatory Bowel Disease; Inflammatory Bowel Disease (IBD)

Treatments: Other: Electronic medical record-based care pathway

Study type: Interventional

Funder types: Other

Identifiers

NCT07167836

STU-2024-1013

Details and patient eligibility

About

Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Alive patients with 2 or more visits to the UT Southwestern adult digestive disease clinic within 3 years of the date of trial commencement including at least one visit within 2 years, and

2. An active inflammatory bowel disease-specific medication, and

3. At least one of the following:

   1. Inflammatory bowel disease on the active problem list
   2. An inflammatory bowel disease invoice diagnosis at least twice in the 3 years prior to trial commencement
   3. An inflammatory bowel disease encounter diagnosis at least twice in the 3 years prior to trial commencement

Exclusion criteria

Patients not meeting inclusion criteria

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

1,000 participants in 2 patient groups

Care pathway arm

Experimental group

Description:

Use of an electronic medical record-based, risk-stratified tool that automates the identification of patients who are overdue for follow up and facilitates a proactive scheduling plan

Treatment:

Other: Electronic medical record-based care pathway

Usual care

No Intervention group

Description:

Standard disease management, monitoring, and follow-up as directed by clinical team